DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that management will participate in
a fireside chat at the Jefferies London Healthcare Conference on
Tuesday, Nov. 14, 2023 at
12:00 p.m. ET (5:00 p.m. GMT). The live webcast may be accessed
under the Investors tab on www.alkermes.com and will be archived
for 14 days.
About Alkermes plc
Alkermes plc is a
fully-integrated, global biopharmaceutical company developing
innovative medicines in the fields of neuroscience and oncology.
The company has a portfolio of proprietary commercial products
focused on alcohol dependence, opioid dependence, schizophrenia and
bipolar I disorder, and a pipeline of product candidates in
development for neurological disorders and cancer. Headquartered
in Dublin, Ireland, Alkermes has a research and
development center in Waltham, Massachusetts; a research
and manufacturing facility in Athlone, Ireland; and a
manufacturing facility in Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alkermes-to-participate-in-the-jefferies-london-healthcare-conference-301980666.html